| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adrenergic targets for the treatment of cognitive deficits in schizophrenia
|
Arnsten, Amy F. T.
|
|
2003
|
174 |
1 |
p. 25-31
|
article
|
| 2 |
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
|
Martin, Laura F.
|
|
2004
|
174 |
1 |
p. 54-64
|
article
|
| 3 |
Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia
|
Castner, Stacy A.
|
|
2004
|
174 |
1 |
p. 111-125
|
article
|
| 4 |
Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists
|
Friedman, Joseph I.
|
|
2004
|
174 |
1 |
p. 45-53
|
article
|
| 5 |
Hippocampal function in cognition
|
Sweatt, J. David
|
|
2004
|
174 |
1 |
p. 99-110
|
article
|
| 6 |
Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects
|
Geyer, Mark A.
|
|
2004
|
174 |
1 |
p. 1-2
|
article
|
| 7 |
Pharmacological manipulation of human working memory
|
Barch, Deanna M.
|
|
2004
|
174 |
1 |
p. 126-135
|
article
|
| 8 |
Practice, learning, and the likelihood of making an error: how task experience shapes physiological response in patients with schizophrenia
|
Holcomb, Henry H.
|
|
2004
|
174 |
1 |
p. 136-142
|
article
|
| 9 |
Preattentional and attentional cognitive deficits as targets for treating schizophrenia
|
Braff, David L.
|
|
2004
|
174 |
1 |
p. 75-85
|
article
|
| 10 |
Pre-attentive processing and schizophrenia: animal studies
|
Ellenbroek, Bart A.
|
|
2003
|
174 |
1 |
p. 65-74
|
article
|
| 11 |
Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia
|
Chudasama, Y.
|
|
2004
|
174 |
1 |
p. 86-98
|
article
|
| 12 |
Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction
|
Lewis, David A.
|
|
2003
|
174 |
1 |
p. 143-150
|
article
|
| 13 |
Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders
|
Roth, Bryan L.
|
|
2003
|
174 |
1 |
p. 17-24
|
article
|
| 14 |
Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
|
Moghaddam, Bita
|
|
2004
|
174 |
1 |
p. 39-44
|
article
|
| 15 |
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
|
Goldman-Rakic, Patricia S.
|
|
2004
|
174 |
1 |
p. 3-16
|
article
|
| 16 |
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications
|
Harrison, Paul J.
|
|
2004
|
174 |
1 |
p. 151-162
|
article
|
| 17 |
The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia
|
Coyle, Joseph T.
|
|
2003
|
174 |
1 |
p. 32-38
|
article
|
Journal description